MARKET

PSTX

Poseida Therapeutics, Inc.
PSTX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.7308
14.04
10.61
925,933,327.00
Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win
Seeking Alpha · 5d ago
Poseida Therapeutics Undergoes Merger and Delisting Changes
TipRanks · 6d ago
Deals of the day-Mergers and acquisitions
Reuters · 6d ago
Roche Finalizes Tender Offer for $1.5B Poseida Biopharma Deal
TipRanks · 6d ago
Roche to close $1.5B acquisition of Poseida Therapeutics
Seeking Alpha · 01/08 07:43
BRIEF-Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer
Reuters · 01/08 06:17
*Roche: 66.11% of Poseida's Shares Were Validly Tendered in Offer
Dow Jones · 01/08 06:15
*Roche Intends to Complete Acquisition of Poseida Therapeutics Later Wednesday
Dow Jones · 01/08 06:12
More

Webull offers Poseida Therapeutics, Inc. stock information, including NASDAQ: PSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTX stock methods without spending real money on the virtual paper trading platform.